Farmers in Kenya are nearing the introduction of Bt maize, a genetically modified (GM) maize variety, pending public and regulatory approval.
The National Biosafety Authority (NBA) is set to analyze feedback received from the public via online submissions and hard copies regarding the application for the market placement of Bt maize. According to Josphat Muchiri, Acting Director of Biosafety Research and Compliance, the NBA will also consult with agencies such as the Kenya Plant Health Inspectorate Service (Kephis), the National Environment Management Authority (Nema), public health authorities, and independent experts before making a final decision.
While research on Bt maize has been conducted by the Kenya Agricultural and Livestock Research Organisation (Kalro), distribution to farmers cannot proceed without NBA approval. Muchiri assured the public of a robust legal and regulatory framework to oversee the safe handling and use of GMOs.
Public participation was conducted in Kakamega, Uasin Gishu, Trans Nzoia, and Machakos counties following a December 6 NBA notice requesting feedback. This comes after a ruling by Justice Oscar Angote of the Environment and Lands Court affirmed that Bt maize poses no threat to Kenyans due to established safety measures.
Bt maize, developed by Kalro and the African Agricultural Technology Foundation, aims to combat pests such as fall armyworms and maize stem borers, which significantly impact maize production.
The NBA’s decision to engage the public aligns with the Biosafety Act, 2009, which mandates public notification and participation for environmental release or cultivation of GM products. Additional regulatory steps, including Environmental Impact Assessments and National Performance Trials, will follow before Bt maize can be commercially released.
